A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes
A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes
A multicenter, randomized, double-blind, placebo-controlled, group-comparison study to investigate the safety and efficacy of OPC-262 in patients with type 2 diabetes
Inclusion Criteria:
Exclusion Criteria:
Chubu Regin, Japan
Chugoku Region, Japan
Hokkaido Region, Japan
Kanto Region, Japan
Kinki Region, Japan
Kyushu Region, Japan
Shikoku Region, Japan
Tohoku Region, Japan